0 CHECKOUT

S&PCORRECT: Mitsui, Sumitomo, Marubeni, And Sojitz Upgraded; Outlook On Mitsubishi To Positive Mar 05

  • ID: 1771120
  • March 2005
  • Standard & Poors

FEATURED COMPANIES

  • Marubeni Corp.
  • Mitsubishi Corp.
  • Mitsui & Co. Ltd.
  • Sojitz Corp.
  • Sumitomo Corp.
  • MORE

Abstract
(Editor's note: In the version of this release published earlier today, Sumitomo Corp.'s core operating profit was incorrectly stated. A corrected version follows.) TOKYO (Standard & Poor's) March 8, 2005--Standard & Poor's Ratings Services today raised its long-term corporate credit ratings on Mitsui & Co. Ltd. and Sumitomo Corp. to 'A-' from 'BBB+', Marubeni Corp. to 'BB' from 'BB-', and Sojitz Corp. to 'BB-' from 'B+'. The outlooks on the ratings on Mitsui, Sumitomo, and Marubeni are positive, and the outlook on Sojitz is stable (see list below). At the same time, Standard & Poor's revised its outlook to positive from stable on the long-term credit rating on Mitsubishi Corp. (A-/Positive/A-2) and affirmed its ratings. The ratings actions affect all...

Companies mentioned in this report are:
- Mitsubishi Corp.
- Mitsui & Co. Ltd.
- Sumitomo Corp.
- Marubeni Corp.
- Sojitz Corp.

Action: Affirmed
Action: Outlook: Positive
Action: Outlook: Stable
Action: Upgraded

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, READ MORE >

Note: Product cover images may vary from those shown

- Mitsubishi Corp.
- Mitsui & Co. Ltd.
- Sumitomo Corp.
- Marubeni Corp.
- Sojitz Corp.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.